Sharon Bio-Medicine Ltd-$ (Delisted) share news and announcements

BSE: 532908Pharmaceuticals & Biotechnology

Last traded ₹3.30 on 28 Mar 2019

Delisted on 20 Feb 2024.

Sharon Bio-Medicine Ltd-$ share news and announcements

831 announcements, routine notices left out, newest first. Page 3 of 17.

May 2022
- 6 May · Board meeting
  SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2022 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
Apr 2022
- 22 Apr · Compliance Of Clause 7 (3) Of The Listing Obligations And Disclosure Requirements Regulations, 2015 (LODR) For The Year Ended 31St March, 2022
  As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby confirm that activities in relation to both physical .... (opens in a new tab)
- 21 Apr · General updates
  Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. (opens in a new tab)
- 21 Apr · Regulation 40(9) Of The SEBI (Listing Obligation &Amp; Disclosure Requirements) Regulation, 2015
  Dear Sir /Madam, In compliance of Regulation 40(9) of the SESI (Listing Obligation & Disclosure Requirements) Regulation 2015, the Certificate for the Year Ended on March 31, 2022 .... (opens in a new tab)
Mar 2022
- 7 Mar · General updates
  Order passed by Hon'ble Supreme Court (opens in a new tab)
- 7 Mar · Order Passed By Hon'ble Supreme Court
  Dear Sir /Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith .... (opens in a new tab)
Feb 2022
Jan 2022
- 28 Jan · Board meeting
  Unaudited Financial Results for the quarter ended December 31, 2021 (opens in a new tab)
- 28 Jan · Board meeting
  SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2022 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
- 18 Jan · Updates
  Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 (opens in a new tab)
- 15 Jan · Shareholding for the Period Ended December 31, 2021
  Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....
- 15 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 13 Jan · Updates
  NCLAT Order dated January 5, 2022 (opens in a new tab)
- 13 Jan · NCLAT Order Copy Dated 5Th January, 2022
  Dear Sir /Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith .... (opens in a new tab)
Dec 2021
- 30 Dec · Updates
  Intimation of Closure of Trading Window (opens in a new tab)
Nov 2021
Oct 2021
- 28 Oct · Updates
  Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 (opens in a new tab)
- 26 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2021 (opens in a new tab)
- 26 Oct · Board meeting
  SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2021 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
- 20 Oct · Shareholding for the Period Ended September 30, 2021
  Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....
- 20 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2021
- 30 Sep · Updates
  Intimation of Closure of Trading Window (opens in a new tab)
Aug 2021
Jul 2021
- 22 Jul · Related Party Transactions
  Subject: Disclosure under Regulation 23(9) of SEBI (LODR) Regulation, 2015 Pursuant to the Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, there were no related party transactions for the half year ended March 31, 2021.Kindly take the above information on your records. (opens in a new tab)
- 22 Jul · Subject: Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulation, 2015
  There were no related party transactions for the half year ended March 31, 2021. .... (opens in a new tab)
- 21 Jul · Updates
  Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and participants) Regulations 2018 Kindly take the same on your record and acknowledge the receipt. (opens in a new tab)
- 20 Jul · Shareholding for the Period Ended June 30, 2021
  Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....
- 16 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2021
Apr 2021
- 28 Apr · Regulation 40(9) Of The SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015
  Dear Sir /Madam, In compliance of Regulation 40(9) of the SESI (Listing Obligation & Disclosure Requirements) Regulation 2015, the Certificate for the Half Year Ended on March 31, 2021 .... (opens in a new tab)